CSA Medical

Funding and NIH signals

• SEC Form D raise Raised $2.91M (Form D filed Jul 23, 2026). SEC Form D 0001403000-26-000004 (Jul 23, 2026)
  Evidence (1 event)

  • Jul 23, 2026 · SEC Form D 0001403000-26-000004
    Name of Issuer: CSA Medical, Inc.; CIK: 1403000; Address: Lexington, MA; Submission type: D; Filing date: 2026-07-23; Industry Group: Other; Date of First Sale: 2026-06-08; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 11217710; Total Amount Sold: 2908295; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Raises and deals from press releases

• Raise Series D · $53M · announced Sep 9, 2024 Company release ↗
  Source quote

  • Sep 9, 2024 · Company release ↗
    “— CSA Medical Inc., developer of The RejuvenAir® System, a Breakthrough Medical Device advancing the power of liquid nitrogen spray cryotherapy for the treatment of chronic bronchitis, today announced the completion of an oversubscribed $53 million Series D preferred stock equity financing”

Raises announced in these releases: $53M disclosed.

From the company’s own releases; this list is partial. All raises and deals